Activity of biogenic silver nanoparticles in planktonic and biofilm-associated Corynebacterium pseudotuberculosis

PeerJ. 2024 Feb 20:12:e16751. doi: 10.7717/peerj.16751. eCollection 2024.

Abstract

Corynebacterium pseudotuberculosis is a gram-positive bacterium and is the etiologic agent of caseous lymphadenitis (CL) in small ruminants. This disease is characterized by the development of encapsulated granulomas in visceral and superficial lymph nodes, and its clinical treatment is refractory to antibiotic therapy. An important virulence factor of the Corynebacterium genus is the ability to produce biofilm; however, little is known about the characteristics of the biofilm produced by C. pseudotuberculosis and its resistance to antimicrobials. Silver nanoparticles (AgNPs) are considered as promising antimicrobial agents, and are known to have several advantages, such as a broad-spectrum activity, low resistance induction potential, and antibiofilm activity. Therefore, we evaluate herein the activity of AgNPs in C. pseudotuberculosis, through the determination of minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), antibiofilm activity, and visualization of AgNP-treated and AgNP-untreated biofilm through scanning electron microscopy. The AgNPs were able to completely inhibit bacterial growth and inactivate C. pseudotuberculosis at concentrations ranging from 0.08 to 0.312 mg/mL. The AgNPs reduced the formation of biofilm in reference strains and clinical isolates of C. pseudotuberculosis, with interference values greater than 80% at a concentration of 4 mg/mL, controlling the change between the planktonic and biofilm-associated forms, and preventing fixation and colonization. Scanning electron microscopy images showed a significant disruptive activity of AgNP on the consolidated biofilms. The results of this study demonstrate the potential of AgNPs as an effective therapeutic agent against CL.

Keywords: Antimicrobial agent; Caseous lymphadenitis; Complementary treatment; Nanotechnology; Small ruminants.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents* / pharmacology
  • Biofilms
  • Corynebacterium Infections* / drug therapy
  • Corynebacterium pseudotuberculosis*
  • Humans
  • Lymphadenitis* / drug therapy
  • Metal Nanoparticles* / therapeutic use
  • Silver / pharmacology

Substances

  • Silver
  • Anti-Bacterial Agents
  • Anti-Infective Agents

Grants and funding

This study was funded by the Fundação de Apoio à Pesquisa e Extensão (FAPEX), through continuous resources obtained by extension projects. Laerte Marlon Santos and Mauricio Alcantara Kalil are PhD fellows from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). Ricardo Wagner Portela is a Technical Development fellow from the Conselho Nacional de Desenvolvimento Científico (CNPQ—Proc. 310058/2022-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.